GSK Pulls H1N1 Vaccine Amid Reports Of Reactions

Law360, New York (November 24, 2009, 2:12 PM EST) -- GlaxoSmithKline PLC is advising Canadian officials to stop administering shots from a batch of the company's H1N1 vaccine after health officials received a higher than expected number of reports of severe allergic reactions.

The U.K.-based pharmaceutical company said Tuesday that it was taking the “cautionary action” because the Public Health Agency of Canada had received a higher number of reports of anaphylaxis with a lot of Arepanrix than it had with other lots of the vaccine. The lot in question contained 172,000 doses, GSK said....
To view the full article, register now.